All posts
-
Skild Has Amazon Backing, a Massive Valuation, and a Ton of Talent – But What Is It?
POSTED 07/30/2025 | By: Brian Heater, Managing Editor, A3 Skild AI has the early markings of a behemoth. Based in 2023 by ability at Silicon Valley flagships, it made waves final twelve months with a $300 million Series A that contains Amazon and Softbank that valued the company at $1.5 billion. A rumored Series B
-
Motion Control Technologies Moving the Warehousing and Logistics Industry Forward
POSTED 07/30/2025 | By: Poornima Apte, A3 Contributing Editor Image the day after day operations in a sizable warehouse. Robotic techniques work right here in several heaps of ways. When a truck backs up correct into a loading dock, an self reliant cell robot (AMR) would possibly well well additionally dump capabilities onto a conveyor belt
-
FID at Malawi project sets Lindian on course to rare earths producer status, raises A$91.5m
Perth-based traveler Lindian Resources has actually secured A$ 91.5-million from institutional capitalists and accepted a last financial investment choice (FID) to construct the in…
-
Medicines exempt from US tariffs – but will probably be affected “any minute now”
Donald Trump is figured out to bring medication production back to the United States. Specialists anticipate the verdicts of a crucial examination right into tolls on medications t…
-
Coloplast’ Q3 earnings underperform analyst forecast
Post-tax earnings concerned DKK 805m versus experts’ expectation of DKK 912m– and contrasted to DKK 1,274 m from the very same duration in 2014.
-
Coloplast creates new business units and shuffles management
Nicolai Buhl, that has actually headed the currently inoperative Persistent Treatment department, is leaving the clinical tool firm.
-
Zealand Pharma CEO plans to use bulging coffers to secure launch of crown jewel
As an outcome of the collaboration contract authorized with Roche, Zealand Pharma has accessibility to a large amount of cash. A great deal of it will certainly be made use of for …
-
CEO of Danish cancer vaccine developer remains confident despite disappointing phase 3 study
She still has confidence that the vaccination will certainly get to the marketplace.
-
Zealand Pharma CEO: Expectations for the obesity market need to be adjusted
” The marketplace has actually been very concentrated on that can accomplish the fastest and biggest weight management,” states the chief executive officer.
